Skip to main content
Home > The Daily Extra > Company News

Chronological Index of : Company News

 Current Issue
  • COMPANY NEWS: Management tracks

    Cancer company Cleave Biosciences Inc. (Burlingame, Calif) said CMO Alessandra Cesano is stepping down. Cleave hired Kanya Rajangam as VP of clinical development. Rajangam was executive director of the oncology and …

    Published on 6/23/2015
  • COMPANY NEWS: 3SBio gets worldwide rights to Apexigen's anti-TNF

    3SBio Inc. (HKSE:1530) received ex-China rights to SSS07 from Apexigen Inc. (San Carlos, Calif.). 3SBio already held rights in China to the humanized mAb that inhibits tumor necrosis factor (TNF) alpha. Neither company …

    Published on 6/22/2015
  • COMPANY NEWS: Anthem reiterates takeover bid for Cigna

    Anthem Inc. (NYSE:ANTM) on Monday reiterated a June 20 bid for Cigna Corp. (NYSE:CI) that Cigna previously rejected -- 184 per share in cash and stock, or $47.4 billion. Anthem said the proposed deal would lead to …

    Published on 6/22/2015
  • COMPANY NEWS: FDA approves Medicines Co.'s Kengreal

    FDA approved Kengreal cangrelor from The Medicines Co. (NASDAQ:MDCO) as an adjunct to percutaneous coronary intervention (PCI) to reduce the risk of periprocedural thrombotic events including myocardial infarction (MI),…

    Published on 6/22/2015
  • COMPANY NEWS: Kite, bluebird partner on HPV-associated cancers

    Kite Pharma Inc. (NASDAQ:KITE) and bluebird bio Inc. (NASDAQ:BLUE) partnered to develop and commercialize second-generation T cell receptor (TCR) candidates against HPV-16 E6 oncoprotein to treat HPV-associated cancers.…

    Published on 6/22/2015
  • COMPANY NEWS: Management tracks

    Rare disease play Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) named Jayson Dallas chief commercial officer, effective Aug. 3. Dallas was general manager in the U.K. at Roche (SIX:ROG; OTCQX:RHHBY).Hepatic company …

    Published on 6/22/2015
  • COMPANY NEWS: Pfizer acquires two meningitis vaccines from GSK

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) will sell quadrivalent meningitis vaccines Nimenrix and Mencevax to Pfizer Inc. (NYSE:PFE) for EUR 115 million ($130.2 million) to address competition concerns raised by the …

    Published on 6/22/2015
  • COMPANY NEWS: EC approves Opdivo for advanced melanoma

    Bristol-Myers Squibb Co. (NYSE:BMY) said the European Commission approved an MAA for Opdivo nivolumab for first-line and previously treated patients with advanced unresectable or metastatic melanoma, regardless of BRAF …

    Published on 6/19/2015
  • COMPANY NEWS: Management tracks

    Oncology company Incyte Corp. (NASDAQ:INCY) said Jim Daly will resign as EVP and CCO. Incyte also hired Barry Flannelly as EVP and general manager U.S., a newly created position.

    Published on 6/19/2015
  • COMPANY NEWS: Aimmune's AR101 gets breakthrough designation

    FDA granted breakthrough therapy designation to AR101 from Aimmune Therapeutics Inc. (Brisbane, Calif.) to treat peanut allergy in children and adolescents aged 4-17.AR101 consists of a standardized complex mixture of …

    Published on 6/18/2015
  • COMPANY NEWS: Bach launches tool linking cancer drug prices to value

    Peter Bach, director of the Center for Health Policy Outcomes at Memorial Sloan Kettering Cancer Center (MSKCC), launched an interactive tool that compares the value-based price of a cancer drug with its market price. …

    Published on 6/18/2015
  • COMPANY NEWS: Management tracks

    Gene therapy company AveXis Inc. (Dallas, Texas) hired Sean Nolan as CEO. He replaces John Carbona, who resigned in April. Nolan was CBO at InterMune Inc., which Roche (SIX:ROG; OTCQX:RHHBY) acquired.Ophthalmic company …

    Published on 6/18/2015
  • COMPANY NEWS: Allergan acquires Kythera for $2.1 billion

    Allergan plc (NYSE:AGN) will acquire Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) for $75 per share, or about $2.1 billion in cash and stock. The price represents a 24% premium over Tuesday's closing price of $60.72. …

    Published on 6/17/2015
  • COMPANY NEWS: Forma achieves milestones in Celgene, Boehringer deals

    Forma Therapeutics Inc. (Watertown, Mass.) received undisclosed milestone payments from Celgene Corp. (NASDAQ:CELG) and Boehringer Ingelheim GmbH (Ingelheim, Germany) under two separate development deals. One milestone …

    Published on 6/17/2015
  • COMPANY NEWS: Management tracks

    The Pharmaceutical Research and Manufacturers of America (PhRMA) elected five new board members. They are Werner Baumann, chairman of the board of management at the Bayer HealthCare AG subsidiary of Bayer AG (Xetra:BAYN…

    Published on 6/16/2015
  • COMPANY NEWS: Almac, Genentech enter cancer collaboration

    The Almac Discovery oncology subsidiary of Almac Group Ltd. (Craigavon, U.K.) granted the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) development and commercialization rights to its preclinical ubiquitin-…

    Published on 6/15/2015
  • COMPANY NEWS: Atara gains on licensing agreement with MSKCC

    Atara Biotherapeutics Inc. (NASDAQ:ATRA) gained $8.19 (17%) to $56.19 after exercising its exclusive, worldwide option to develop and commercialize three allogeneic T cell therapy programs from Memorial Sloan Kettering …

    Published on 6/15/2015
  • COMPANY NEWS: FDA partners with PatientsLikeMe for post-market data

    PatientsLikeMe Inc. (Cambridge, Mass.) granted FDA access to its patient-reported data, which the agency said it will use to identify risks and benefits of drugs. The agency said PatientsLikeMe's adverse event data have…

    Published on 6/15/2015
  • COMPANY NEWS: Management tracks

    The Biotechnology Industry Organization (BIO) elected Ron Cohen chair of its board of directors and chair of its health section governing board. Cohen, the president and CEO of Acorda Therapeutics Inc. (NASDAQ:ACOR), …

    Published on 6/15/2015
  • COMPANY NEWS: Servier gets EU rights to Taiho's TAS-102

    Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan) granted Servier (Neuilly-sur-Seine, France) an exclusive license to TAS-102 trifluridine/tipracil in the EU. An MAA for the therapy is under EMA review to treat refractory …

    Published on 6/15/2015
  • COMPANY NEWS: Management tracks

    NIH said Deputy Director of Extramural Research Sally Rockey will resign. She will become director of the Foundation for Food and Agriculture Research. NIH also named Walter Koroshetz director of the National Institute …

    Published on 6/12/2015
  • COMPANY NEWS: Seres' SER-109 gets breakthrough designation

    FDA granted breakthrough therapy designation to microbiome therapy SER-109 from Seres Therapeutics Inc. (Cambridge, Mass.) to treat recurrent Clostridium difficile infections. Seres expects data from a Phase II study of…

    Published on 6/12/2015
  • COMPANY NEWS: J&J Innovation unveils 17 deals

    The Johnson & Johnson Innovation unit of Johnson & Johnson (NYSE:JNJ) announced 17 new collaborations running the gamut from disease biology research to studying the real-world use of approved drugs. Several early …

    Published on 6/11/2015
  • COMPANY NEWS: PeptiDream gets milestone as BMS selects pre-IND candidate

    PeptiDream Inc. (Tokyo:4587) gained Y1,320 (11%) to Y13,300 on Thursday on news it received an undisclosed milestone payment from Bristol-Myers Squibb Co. (NYSE:BMY) after the pharma designated a compound covered by the…

    Published on 6/11/2015
  • COMPANY NEWS: CMO Morrison leaving AstraZeneca

    Briggs Morrison will step down as CMO and EVP of global medicines development of AstraZeneca plc (LSE:AZN; NYSE:AZN), effective Friday. Morrison will become CEO of an undisclosed privately held pharmaceutical company, …

    Published on 6/10/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993